# #19 – Dave Feldman: stress testing the lipid energy model

**Channel:** Peter Attia MD
**Upload Date:** 2020-01-01
**URL:** https://www.youtube.com/watch?v=kRxeyaNWmHw
**Duration:** 190 minutes

## Description

Original release date: 10/8/2018

In this episode, Dave Feldman, discusses his journey from software engineer to n=1 experimenter, his experience with low-carbohydrate diets, and his hypothesis that cholesterol levels are influenced by energy metabolism.

Note: this podcast gets technical at times and refers to many visuals during the discussion. The graphics, figures, and tables alluded to are provided in the show notes. In addition, there is commentary by Thomas Dayspring, M.D., in the show notes, providing corrections, clarifications, and amplification. Dave Feldman provided many graphics and some additional comments that are included in the show notes.

We discuss:
-Peter’s synthesis of Dave’s energy model [5:00];
-Dave’s lipid energy model;
-Dave’s inversion pattern experiments;
-Dave’s journey from software engineer to cholesterol enthusiast [15:00];
-Standard blood panels, sterol panels, and what moves the needle when it comes to particle numbers [18:30];
-Hyper-responders [20:00];
-Lipoprotein transport [33:45];
-The lean mass hyper-responder phenotype [47:30];
-The progression of atherosclerosis, CAC, and CIMT [52:30];
-Testing for oxidized LDL [55:30];
-All-cause mortality and clinical endpoints [1:01:15];
-What does “LDL as causal” mean? [1:05:15];
-Dave’s low carb cholesterol challenge and drug & genetic study qualifications [1:13:15];
-If all other markers are in a healthy range, but LDL-P is high, is the patient at risk? A couple of case studies, and a self-experiment [1:27:30];
-Peter’s three-day exercise and ketosis experiment [1:41:00];
-What are remnant lipoproteins? [1:45:00];
-What might cause lean mass hyper-responders to have higher LDL particle numbers? [1:53:30];
-A case study from Dave of a lean mass hyper-responder [1:56:30];
-Mass balance and cholesterol flux [2:05:30];
-Can a higher degree of cholesterol explain the lean mass hyper-responder phenotype? [2:10:00];
-Peter’s LDL during his keto-fast-keto experiment [2:13:30];
-Does substituting saturated fats with monounsaturated fats lower LDL-P and LDL-C? [2:15:45];
-Dave’s carb-swap experiments [2:22:15];
-Dave’s carotid intima-media thickness tests [2:41:15];
-Looking for studies that stratify for high HDL-C and low TG alongside low and high LDL-C [2:53:00]; and
-More

Show notes page: https://peterattiamd.com/davefeldman/

For the transcript of this episode where there is more commentary from Tom Dayspring: https://peterattiamd.com/davefeldmantranscript/

About:
The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 10 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. 

Peter is the founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City, focusing on the applied science of longevity. The practice applies nutritional biochemistry, exercise physiology, sleep physiology, techniques to increase distress tolerance, lipidology, pharmacology, and four-system endocrinology to increase lifespan (delaying the onset of chronic disease), while simultaneously improving healthspan (quality of life).

Learn more: https://peterattiamd.com/
Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Play: http://bit.ly/TheDriveGooglePlay

## AI Summary

Here's a comprehensive analysis of this episode of The Drive podcast with Dave Feldman:

1. **Executive Summary**:
This episode features an in-depth discussion between Peter Attia and Dave Feldman about lipids, cholesterol, and cardiovascular disease risk. The conversation centers around Feldman's "energy model" hypothesis regarding lean mass hyper-responders (people who develop very high LDL cholesterol on low-carb diets) and whether their elevated LDL represents increased cardiovascular risk. Attia challenges several aspects of Feldman's model, particularly regarding mass balance and the source of increased cholesterol in these individuals.

2. **Key Medical/Scientific Points**:
- LDL particle half-life is approximately one day under normal conditions [1:40:42]
- About 40% of LDL comes directly from the liver [40:27]
- Oxidized LDL testing can measure escaped particles from the subendothelial space [55:43]
- Three factors necessary for atherosclerosis: lipoprotein burden, endothelial function, and inflammatory response [1:07:25]

3. **Health Optimization Tips**:
Universal recommendations:
- Monitor both LDL-P and LDL-C, not just standard lipid panel [19:05]
- Consider advanced lipid testing before starting low-carb diet [20:20]

Context-specific recommendations:
- For lean mass hyper-responders: consider reducing saturated fat while maintaining ketosis [2:19:22]
- Monitor oxidized LDL as a marker of cardiovascular risk [55:43]

4. **Supplements & Medications**:
Medications mentioned:
- Statins [1:24:59]
- PCSK9 inhibitors (Repatha) [1:03:59]
- Zetia [1:08:21]

5. **Biomarkers & Testing**:
Key tests discussed:
- LDL-P (particle number)
- LDL-C (cholesterol)
- Oxidized LDL
- Des-mosterol (cholesterol synthesis marker)
- Phytosterols
- LP-PLA2
- Calcium score
- CIMT

6. **Notable Quotes**:
"LDL is necessary but not sufficient for atherosclerosis" - Peter Attia [1:07:25]

"The body of evidence implicating LDL as having a causal role in the pathogenesis of atherosclerosis is on a different level from the body of literature that gave us the food pyramid" - Peter Attia [2:31:00]

7. **Follow-up Questions**:
1. What is the exact mechanism of cholesterol synthesis upregulation in lean mass hyper-responders?
2. How does exercise type (resistance vs. endurance) affect LDL particle dynamics?
3. What role does liver glycogen status play in VLDL secretion?
4. How can we better measure remnant lipoproteins clinically?

This episode provides valuable insights into the complexity of lipid metabolism and cardiovascular risk assessment, particularly in the context of low-carbohydrate diets. The discussion highlights the importance of considering multiple factors beyond basic lipid panels when assessing cardiovascular risk.
